CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device? Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent 5-Year Outcomes of the Randomized BIOFLOW-II Trial Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document Mortality Differences Associated With Treatment Responses in CANTOS and FOURIER: Insights and Implications Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice : An NCDR Registry to Practice Project

Guideline2016 Jul 14;37(27):2129-2200.

JOURNAL:Eur Heart J. Article Link

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski P, Voors AA, ESC Scientific Document Group. et al. Keywords: Arrhythmias; Cardiac resynchronization therapy; Co-morbidities; Diagnosis; Ejection fraction; Guidelines; Heart failure; Hospitalization; Mechanical circulatory support; Multidisciplinary management; Natriuretic peptides; Neuro-hormonal antagonists; Pharmacotherapy; Transplantation

Full Text PDF